US Pharma and Biotech Summit

The US Pharma and Biotech Summit returned to New York on May 11, 2022. Industry leaders and FT journalists gathered to discuss regional and global trends in areas such as drug discovery, clinical development and market access. How is American investment in life sciences evolving? What are the prospects for healthcare reform? How can pharma companies become more patient-centric? Delegates joined us in-person and online to learn from experts, engage with leaders and network with peers.

Driving investment

How is the life sciences investment landscape evolving? What shifts are we seeing in M&A activity? How do investors decide where to put their money? To what extent is ESG shaping investment decisions?

Accelerating innovation

What will transform pharma the most over the next 5-10 years? What is the true potential of AI?  What role will cross-industry collaboration continue to play? How can pharma workforces become more productive and externally focused? 

Enhancing access

How can pharma companies become more patient-centric? How could proposed US healthcare reforms affect the industry? How can cell and gene therapies be made more affordable and accessible? 

Get access to all sessions on-demand.

Not a subscriber of the FT?

When you purchase a ticket to one of our events you will receive a trial subscription for £1 giving you full digital access to essential news and opinion.

Speaking Opportunities

Ciaran Larkin
ciaran.larkin@ft.com

Sponsorship Opportunities 

James Priest
james.priest@ft.com

click here for more information

Delegate Services 

Sean Hammond
sean.hammond@ft.com

© Financial Times Live

FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice